Adenoviral mediated gene transfer of PDGF‐B enhances wound healing in type I and type II diabetic wounds
- 22 September 2004
- journal article
- research article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 12 (5) , 497-504
- https://doi.org/10.1111/j.1067-1927.2004.12501.x
Abstract
We have shown that the genetically diabetic mouse (C57BLKS/J‐m+/+Leprdb) has a wound healing and neovascularization deficit associated with an inability to recruit endothelial precursor cells (EPCs) to the wound. This may account for a fundamental mechanism in impaired diabetic wound healing. We hypothesized that the adenoviral mediated overexpression of platelet‐derived growth factor‐B (PDGF‐B) would enhance wound healing, improve neovascularization, and recruit EPCs to the epithelial wound in three diabetic mouse models. Eight‐mm full‐thickness flank wounds were made in db/db, nonobese NOD/Ltj, streptozotocin, and C57BLKS/J mice. Wounds were treated with either 1 × 108 PFU Ad‐PDGF‐B or Ad LacZ or phosphate buffered saline solution. Wounds harvested at seven days were analyzed for epithelial gap, blood vessel density, granulation tissue area, and EPCs per high powered field. All three diabetic models have a significant wound healing and neovascularization defect compared to C57BLKS/J controls. Adenoviral‐PDGF‐B treatment significantly enhanced epithelial gap closure in db/db, streptozotocin, and nonobese NOD/Ltj mice as compared to diabetic phosphate buffered saline solution or Ad LacZ controls. A similar increase in the formation of granulation tissue and vessel density was also observed. All three models had reduced levels of GATA‐2 positive EPCs in the wound bed that was corrected by the adenoviral mediated gene transfer of PDGF. EPC recruitment was positively correlated with neovascularization and wound healing. Three different diabetic models have a wound healing impairment and a decreased ability to recruit EPCs. The vulnerary effect of adenoviral mediated gene therapy with PDGF‐B significantly enhanced wound healing and neovascularization in diabetic wounds. The PDGF‐B mediated augmentation of EPC recruitment to the wound bed may be a fundamental mechanism of these results.Keywords
This publication has 26 references indexed in Scilit:
- Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trialThe Lancet, 2002
- Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factorsGene Therapy, 2002
- Increased Susceptibility to Streptozotocin-Induced β-Cell Apoptosis and Delayed Autoimmune Diabetes in Alkylpurine- DNA-N-Glycosylase-Deficient MiceMolecular and Cellular Biology, 2001
- Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac functionNature Medicine, 2001
- Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularizationProceedings of the National Academy of Sciences, 2000
- Adenoviral-Mediated Overexpression of Platelet-Derived Growth Factor-B Corrects Ischemic Impaired Wound HealingJournal of Investigative Dermatology, 1999
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997
- Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db MiceCell, 1996
- Laser Doppler velocimetry and platelet-derived growth factor as prognostic indicators for the healing of ulcers and ischaemic lesions of the lower limbCardiovascular Surgery, 1995
- A Phase II Study to Evaluate Recombinant Platelet-Derived Growth Factor-BB in the Treatment of Stage 3 and 4 Pressure UlcersArchives of Surgery, 1994